期刊文献+

表面活性素体外抗菌效果研究 被引量:1

Antibacterial Effect of Surfactin in Vitro
下载PDF
导出
摘要 表面活性素(Surfactin)主要是由芽孢杆菌属产生的具有表面活性的微生物衍生化合物,具有抗细菌、真菌、寄生虫和病毒等特性。为进一步研究表面活性素对动物源病原菌的体外抑制作用,采用牛津杯法测定了表面活性素对产气荚膜梭菌、金黄色葡萄球菌、大肠杆菌和沙门氏菌的抑菌圈直径;采用两倍稀释法测定了表面活性素、杆菌肽和亚甲基水杨酸杆菌肽对4种产气荚膜梭菌的体外最低抑菌浓度(MIC)。结果表明:表面活性素对产气荚膜梭菌的抑菌圈直径均超过了15 mm,对金黄色葡萄球菌的抑菌圈直径为8.78 mm,对大肠杆菌和沙门氏菌没有产生抑菌圈,同时表面活性素与抗生素杆菌肽对产气荚膜梭菌的抑菌能力相近。 Surfactin is mainly a microbial derivative compound with surface activity produced by Bacillus. It has antibacterial, antifungal, antiparasitic and antiviral properties. In order to further study the in vitro antibacterial effect of surfactant on animal-derived pathogenic bacteria, the Oxford cup method was used to determine the diameter of the inhibition zone of surfactant on Clostridium perfringens, Staphylococcus aureus, Escherichia coli and Salmonella;two-fold dilution method was used to determine the minimum inhibitory concentration(MIC) of surfactant,bacitracin and bacitracin methylene disalicylate against four species of Clostridium perfringens in vitro. The results showed that the diameter of the inhibition zone of surfactin against Clostridium perfringens was more than 15 mm,the diameter of the inhibition zone against Staphylococcus aureus was 8.78 mm, and there was no zone of inhibition against E. coli and Salmonella. At the same time, the inhibitory ability of surfactin against Clostridium perfringens was similar to that of antibiotic bacitracin.
作者 赵宾 白静 ZHAO Bin;BAI Jing(Beijing Enhalor International Tech Co.,Ltd.,Beijing 100081,China;Jinghai Affiliated School of Beijing Normal University,Tianjin 301636,China)
出处 《饲料博览》 CAS 2022年第1期36-39,43,共5页 Feed Review
关键词 表面活性素 抗菌 产气荚膜梭菌 大肠杆菌 替抗 surfactin antibacteria Clostridium perfringens Escherichia coli antibiotic substitution
  • 相关文献

参考文献8

二级参考文献70

  • 1吕应年,杨世忠,牟伯中.脂肽的分离纯化与结构研究[J].微生物学通报,2005,32(1):67-73. 被引量:35
  • 2刘向阳,杨世忠,牟伯中.微生物脂肽的结构[J].生物技术通报,2005,21(4):18-26. 被引量:30
  • 3覃尚忠.达托霉素研究进展[J].中国药事,2006,20(6):375-377. 被引量:5
  • 4李云霄,金鑫,张营,单雪梅,于丹.魏氏梭菌病诊断方法研究进展[J].动物医学进展,2007,28(7):88-93. 被引量:31
  • 5HANCOCK R E W,CHAPPLE D S.Peptide antibiotics[J].Antimicrob Agents Chemother,1999,43:1317-1323.
  • 6HANCOCK R E W,DIAMOND G.The role of cationic antimicrobial peptides in innate host defences[J].Trends Microbiol,2000,8:402-410.
  • 7ANDREW D,RIVAS L.Animal antimicrobial peptides:an overview[J].Biopoly mers,1996,47:415-433.
  • 8Knapp O, Benz R, Gibert M, et al. Interaction of Clostridium perfringens iota toxin with lipid bilayer membranes. Demon- stration of channel formation by the activated binding compo- nent Ih and channel block by the enzyme component Ia [J]. J Biol Chem, 2002, 277 (Pt8) : 6143-6152.
  • 9Petit L, Gibert M, Popff M R. Clostridium perfringens: tox- in type and genotype [J]. Trend Microbiol, 1999,7 (3) : 104- 110.
  • 10Lindstrom M, Heikinheimo A, Lahti P, et al. Novel insights into the epidemiology of Clostridiurn perfringens type A food poisoning[J]. Food Microbiol, 2011,28 : 192-198.

共引文献23

同被引文献16

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部